[1] Tawfeek GM,Bishara SA,Sarhan RM,et al. Genotypic,physiological,and biochemical characterization of potentially pathogenic Acanthamoeba isolated from the environment in Cairo,Egypt[J].Parasitol Res,2016,115(5):1871-1881.
[2] 刘斐,玄英花,郑善子.棘阿米巴性角膜炎治疗的研究[J].中国药学杂志,2012,47(22):1864-1866.
[3] Kilvington S,Hughes R,Byas J,et al.Activities of therapeutic agents and myristamidopropyl dimethylamine against Acanthamoeba isolates[J].Antimicrob Agents Chemother,2002,46(6):2007-2009.
[4] 李方方,徐燕丽,张秀群,等.伏立康唑预防侵袭性真菌感染有效性及安全性的荟萃分析[J].中国感染与化疗杂志,2012,12(6):453-458.
[5] Raederstorff D,Rohmer M.Sterol biosynthesis de nova via cycloartenol by the soil ameba Acanthamoeba polyphaga[J].BiochemJ,1985,231(3):609-615.
[6] Kowalski RP,Abdel-Aziz S,Romanowski EG,et al.Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs[J].JAMA Ophthalmol,2013,131(11):1459-1462.
[7] Martín-Navarro CM, López-Arencibia A, Sifaoui I,et al.Statins and voriconazole induce programmed cell death in Acanthamoeba castellanii[J].Antimicrob Agents Chemother,2015,59(5):2817-2824.
[8] Iovieno A,Miller D,Ledee DR,et al.Cysticidal activity of antifungals against different genotypes of Acanthamoeba[J].Antimicrob Agents Chemother,2014,58(9):5626-5628.
[9] 郑善子,申成华,王铁,等.棘阿米巴的分离及实验室培养[J].延边大学医学学报,2003,26(3):168-170.
[10] Visvesvara GS.Amebic meningoencephalitides and keratitis:challenges in diagnosis and treatment[J].Curr Opin Infecr Dis,2010,23(6):590-594.
[11] 刘斐.抗真菌药在体外对棘阿米巴杀伤作用的实验研究[D].延吉:延边大学,2012:1-39.
[12] Smith FR,Korn ED.7-Dehydrostigmasterol and ergosterol:major sterols of an amoeba[J].Lipid Res,1968,9(4):405-408.
[13] Mehdi H,Garg NK.Changes in the lipid composition and activities of isocitrate dehydrogenase and isocitrate lyase during encystation of Acanthamoeba culbertsoni strain A-1[J].Trans R Soc Trop Med Hyg,1987,81(4):633-636.
[14] Mehdi H,Garg HS,Garg NK,et al.Sterols of Acanthamoeba culbertsoni strain A-1[J]. Steroids,1988,51(5/6):551-558.
[15] 陈祖基.实用眼科药理学[M].北京:中国科学技术出版社,1993:148-149. |